ID

42285

Descrizione

Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer

Keywords

  1. 04/05/21 04/05/21 -
  2. 04/05/21 04/05/21 -
Titolare del copyright

GlaxoSmithKline

Caricato su

4 maggio 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)

Form D; Patient Symptom Assessment; Topotecan Post-Study Minimal Follow-Up Report (Month of Report; Outcome, Form D)

Administrative
Descrizione

Administrative

Alias
UMLS CUI-1
C1320722
Centre Number
Descrizione

Centre Number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Patient Number
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Patient Initials
Descrizione

Patient Initials

Tipo di dati

text

Alias
UMLS CUI [1]
C2986440
Form D
Descrizione

Form D

Alias
UMLS CUI-1
C0011065
Cause of Death
Descrizione

Call SB and report death.

Tipo di dati

text

Alias
UMLS CUI [1]
C0007465
Specify other cause of death
Descrizione

Specify other cause of death

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C2348235
Date of Death
Descrizione

Date of Death

Tipo di dati

date

Alias
UMLS CUI [1]
C1148348
Was a post-mortem done?
Descrizione

If "Yes" please summarise findings (include diagnosis)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004398
Please summarise autopsy findings
Descrizione

Include diagnosis

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0004398
UMLS CUI [1,2]
C0243095
UMLS CUI [1,3]
C0011900
Physician's Signature
Descrizione

Physician's Signature

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519316
UMLS CUI [1,2]
C0031831
Signature Date
Descrizione

Signature Date

Tipo di dati

date

Alias
UMLS CUI [1]
C0807937
Patient Symptom Assessment
Descrizione

Patient Symptom Assessment

Alias
UMLS CUI-1
C3494437
Course Number
Descrizione

If Course 1, please indicate the visit

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0750729
If Course 1, please indicate the visit
Descrizione

If Course 1, please indicate the visit

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0750729
UMLS CUI [1,2]
C0545082
Date of Assessment
Descrizione

Date of Assessment

Tipo di dati

date

Alias
UMLS CUI [1]
C2985720
Patient Symptom Assessment
Descrizione

Patient Symptom Assessment

Alias
UMLS CUI-1
C3494437
Symptom
Descrizione

Symptom

Tipo di dati

integer

Alias
UMLS CUI [1]
C1457887
Symptom Intensity
Descrizione

Symptom Intensity

Tipo di dati

integer

Alias
UMLS CUI [1]
C0518690
Topotecan Post-Study Minimal Follow-Up Report: Month of Report
Descrizione

Topotecan Post-Study Minimal Follow-Up Report: Month of Report

Alias
UMLS CUI-1
C1704685
UMLS CUI-2
C0146224
UMLS CUI-3
C0439231
UMLS CUI-4
C0684224
Please mark the appropriate box to indicate month of report
Descrizione

Please mark the appropriate box to indicate month of report

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0439231
UMLS CUI [1,2]
C0684224
Specify Other month
Descrizione

Specify Other month

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1518544
UMLS CUI [1,2]
C0566251
UMLS CUI [1,3]
C0205394
UMLS CUI [2]
C2348235
Topotecan Post-Study Minimal Follow-Up Report: Outcome
Descrizione

Topotecan Post-Study Minimal Follow-Up Report: Outcome

Alias
UMLS CUI-1
C1704685
UMLS CUI-2
C0146224
UMLS CUI-3
C1547647
Has the patient died?
Descrizione

Has the patient died?

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011065
If patient died, enter date of last patient contact
Descrizione

i.e. visit, telephone

Tipo di dati

date

Alias
UMLS CUI [1]
C0805839
Was the patient lost to follow-up?
Descrizione

Was the patient lost to follow-up?

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1302313
Has disease progressed?
Descrizione

Has disease progressed?

Tipo di dati

integer

Alias
UMLS CUI [1]
C1335499
Date of first documented disease progression since the Topotecan study conclusion
Descrizione

Date of first documented disease progression since the Topotecan study conclusion

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0242656
UMLS CUI [2,1]
C1707478
UMLS CUI [2,2]
C0146224
Please mark box to indicate any post study cancer therapy received
Descrizione

Please mark box to indicate any post study cancer therapy received

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1882428
UMLS CUI [1,2]
C0920425
Chemotherapy - date treatment started
Descrizione

Chemotherapy - date treatment started

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1531783
UMLS CUI [1,2]
C0392920
Radiotherapy - date treatment started
Descrizione

Radiotherapy - date treatment started

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1531783
UMLS CUI [1,2]
C0392920
Surgery - date treatment started
Descrizione

Surgery - date treatment started

Tipo di dati

date

Alias
UMLS CUI [1,1]
C3173309
UMLS CUI [1,2]
C0543467
Hormonal - date treatment started
Descrizione

Hormonal - date treatment started

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1531783
UMLS CUI [1,2]
C0279025
Immunotherapy - date treatment started
Descrizione

Immunotherapy - date treatment started

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1531783
UMLS CUI [1,2]
C0021083
Topotecan Post-Study Minimal Follow-Up Report: Form D - (To be completed if the patient died)
Descrizione

Topotecan Post-Study Minimal Follow-Up Report: Form D - (To be completed if the patient died)

Alias
UMLS CUI-1
C1704685
UMLS CUI-2
C0146224
UMLS CUI-3
C0011065
Cause of Death
Descrizione

Cause of Death

Tipo di dati

text

Alias
UMLS CUI [1]
C0007465
Specify other Cause of Death
Descrizione

Specify other Cause of Death

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C0205394
UMLS CUI [2]
C2348235
Date of Death
Descrizione

Date of Death

Tipo di dati

date

Alias
UMLS CUI [1]
C1148348
Was a post mortem done?
Descrizione

If "Yes", summarise findings

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004398
Summarise autopsy findings
Descrizione

Include diagnosis.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0004398
UMLS CUI [1,2]
C0243095
Topotecan Post-Study Minimal Follow-Up Report: Investigator's Signature
Descrizione

Topotecan Post-Study Minimal Follow-Up Report: Investigator's Signature

Alias
UMLS CUI-1
C1704685
UMLS CUI-2
C0146224
UMLS CUI-3
C2346576
Investigator's Signature
Descrizione

I certify that I have reviewed the follow-up data and that all information is complete and accurate.

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Investigator's Signature Date
Descrizione

Investigator's Signature Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008

Similar models

Form D; Patient Symptom Assessment; Topotecan Post-Study Minimal Follow-Up Report (Month of Report; Outcome, Form D)

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C2348585 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Form D
C0011065 (UMLS CUI-1)
Item
Cause of Death
text
C0007465 (UMLS CUI [1])
Code List
Cause of Death
CL Item
Progressive Disease (P)
CL Item
Toxicity: Haematologic (Complete Adverse Experience form) (H)
CL Item
Toxicity: Non-Haematologic (Complete Adverse Experience form) (N)
CL Item
Other, specify (Complete Adverse Experience form) (O)
Specify other cause of death
Item
Specify other cause of death
text
C0007465 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Date of Death
Item
Date of Death
date
C1148348 (UMLS CUI [1])
Was a post-mortem done?
Item
Was a post-mortem done?
boolean
C0004398 (UMLS CUI [1])
Please summarise autopsy findings
Item
Please summarise autopsy findings
text
C0004398 (UMLS CUI [1,1])
C0243095 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
Physician's Signature
Item
Physician's Signature
text
C1519316 (UMLS CUI [1,1])
C0031831 (UMLS CUI [1,2])
Signature Date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Item Group
Patient Symptom Assessment
C3494437 (UMLS CUI-1)
Course Number
Item
Course Number
integer
C0237753 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Item
If Course 1, please indicate the visit
integer
C0750729 (UMLS CUI [1,1])
C0545082 (UMLS CUI [1,2])
Code List
If Course 1, please indicate the visit
CL Item
Screening (1)
CL Item
Prenext Course (2)
Date of Assessment
Item
Date of Assessment
date
C2985720 (UMLS CUI [1])
Item Group
Patient Symptom Assessment
C3494437 (UMLS CUI-1)
Item
Symptom
integer
C1457887 (UMLS CUI [1])
Code List
Symptom
CL Item
Shortness of Breath (1)
CL Item
Cough (2)
CL Item
Chest pain (3)
CL Item
Coughing up blood (4)
CL Item
Loss of appetite (5)
CL Item
Interference with sleep (6)
CL Item
Hoarseness (7)
CL Item
Fatigue (8)
CL Item
Interference with daily activities (9)
Item
Symptom Intensity
integer
C0518690 (UMLS CUI [1])
Code List
Symptom Intensity
CL Item
Not at all (1)
CL Item
A Little (2)
CL Item
Quite A Bit (3)
CL Item
Very Much (4)
Item Group
Topotecan Post-Study Minimal Follow-Up Report: Month of Report
C1704685 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C0439231 (UMLS CUI-3)
C0684224 (UMLS CUI-4)
Item
Please mark the appropriate box to indicate month of report
integer
C0439231 (UMLS CUI [1,1])
C0684224 (UMLS CUI [1,2])
Code List
Please mark the appropriate box to indicate month of report
CL Item
3 (1)
CL Item
6 (2)
CL Item
9 (3)
CL Item
12 (4)
CL Item
15 (5)
CL Item
18 (6)
CL Item
21 (7)
CL Item
24 (8)
CL Item
Other, specify (9)
Specify Other month
Item
Specify Other month
text
C1518544 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [2])
Item Group
Topotecan Post-Study Minimal Follow-Up Report: Outcome
C1704685 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C1547647 (UMLS CUI-3)
Has the patient died?
Item
Has the patient died?
boolean
C0011065 (UMLS CUI [1])
If patient died, enter date of last patient contact
Item
If patient died, enter date of last patient contact
date
C0805839 (UMLS CUI [1])
Was the patient lost to follow-up?
Item
Was the patient lost to follow-up?
boolean
C1302313 (UMLS CUI [1])
Item
Has disease progressed?
integer
C1335499 (UMLS CUI [1])
Code List
Has disease progressed?
CL Item
No (1)
CL Item
Yes (2)
CL Item
N/A (If patient progressed on study) (3)
Date of first documented disease progression since the Topotecan study conclusion
Item
Date of first documented disease progression since the Topotecan study conclusion
date
C0011008 (UMLS CUI [1,1])
C0242656 (UMLS CUI [1,2])
C1707478 (UMLS CUI [2,1])
C0146224 (UMLS CUI [2,2])
Item
Please mark box to indicate any post study cancer therapy received
integer
C1882428 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
Code List
Please mark box to indicate any post study cancer therapy received
CL Item
None (1)
CL Item
Chemotherapy (2)
CL Item
Radiotherapy (3)
CL Item
Surgery (4)
CL Item
Hormonal (5)
CL Item
Immunotherapy (6)
Chemotherapy - date treatment started
Item
Chemotherapy - date treatment started
date
C1531783 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Radiotherapy - date treatment started
Item
Radiotherapy - date treatment started
date
C1531783 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Surgery - date treatment started
Item
Surgery - date treatment started
date
C3173309 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
Hormonal - date treatment started
Item
Hormonal - date treatment started
date
C1531783 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
Immunotherapy - date treatment started
Item
Immunotherapy - date treatment started
date
C1531783 (UMLS CUI [1,1])
C0021083 (UMLS CUI [1,2])
Item Group
Topotecan Post-Study Minimal Follow-Up Report: Form D - (To be completed if the patient died)
C1704685 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C0011065 (UMLS CUI-3)
Item
Cause of Death
text
C0007465 (UMLS CUI [1])
Code List
Cause of Death
CL Item
Progressive Disease (P)
CL Item
Other, specify (O)
Specify other Cause of Death
Item
Specify other Cause of Death
text
C0007465 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [2])
Date of Death
Item
Date of Death
date
C1148348 (UMLS CUI [1])
Was a post mortem done?
Item
Was a post mortem done?
boolean
C0004398 (UMLS CUI [1])
Summarise autopsy findings
Item
Summarise autopsy findings
text
C0004398 (UMLS CUI [1,1])
C0243095 (UMLS CUI [1,2])
Item Group
Topotecan Post-Study Minimal Follow-Up Report: Investigator's Signature
C1704685 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C2346576 (UMLS CUI-3)
Investigator's Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Investigator's Signature Date
Item
Investigator's Signature Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial